News and Insights of 3D Printing and Manufacturing
3D LifePrints, a leading provider of personalized surgery that has supplied thousands of patient-specific devices in the UK and Europe, and more recently in the US, has received FDA 510(k) clearance for the company’s cranio-maxillofacial products and services, which are included in the EmbedMed platform. This clearance follows the company’s ISO 13485 medical certification in 2021.
Biomedical technology company, ActivArmor, through its partnership with US-based 3D printer manufacturer, Fusion3, is expanding its distribution model to bring the company’s hygienic, waterproof, plastic custom cast fabrication directly into hospitals and clinics across the country.
To accelerate the transition from preclinical studies with laboratory animals to clinical studies with humans, specialists at the biotechnological research laboratory 3D Bioprinting Solutions (3DBio) developed a method for the scalable production of 3D spheroids in the quantities necessary to accurately determine the specific activity of pharmacological molecules in the body of COVID-19 infected patients, thus accelerating the discovery process for anti-COVID-19 drugs.
Welcome to this month’s AM Focus Medical. For the entire month of February, we are going to zoom in on the many possibilities that additive manufacturing is offering today to medical companies. In this episode, we look at Boston Scientific additive manufacturing and how one of the largest medical companies in the world is working with some of the smallest metal 3D printed components ever created. More episodes are still to come. At the end of the month, all the best content will be featured in 3dpbm’s Medical AM Focus 2020 eBook.
Pharmaceutical company Merck and German custom additive manufacturing specialist AMCM (sister company of EOS) have announced a collaboration through which they will develop 3D printed tablet formulations. The partnership aims to create a tablet 3D printing process that conforms to Good Manufacturing Practice (GMP) standards for clinical trials and, eventually, for commercial manufacturing services.
Welcome to this month’s AM Focus: Medical. For the entire month of February, we are going to zoom in on the many possibilities that additive manufacturing is offering today to medical companies. In this article, we’re giving you a dose of FabRx, a pharmaceutical biotech company that develops pharmaceutical 3D printers and 3D printed tablets. Upcoming articles in the AM Focus will span innovative startups to giant multinational corporations, all of which are using AM in exciting ways. At the end of the month all the best content will be featured in 3dpbm’s Medical AM Focus 2020 eBook.
The U.S. Food and Drug Administration (FDA) has issued approval for patient-specific airway stents made with 3D printing. The custom stents, which are used to help patients with breathing disorders, were developed by Dr. Tom Gildea, a physician at the Cleveland Clinic.